InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

ADMA BIOLOGICS, INC.

ADMA Clue Score77
United States Fiscal year ends December CIK 0001368514 Results filed 4 Nov 2026
Add to watchlist

What the insiders did Balanced

Individual transactions

38
Insider
Date
Role
Action
Shares
Price
Amount
Adam S Grossman
5 Nov 2026
President and CEO
Sold after exercise
42,000
$12.00
$504.00K
Adam S Grossman
5 Nov 2026
President and CEO
Sold after exercise
105,000
$12.00
$1.26M
Adam S Grossman
16 Mar 2026
President and CEO
Sold after exercise
6,000
$15.16
$90.96K
Adam S Grossman
16 Mar 2026
President and CEO
Sold after exercise
15,000
$15.16
$227.40K
Kaitlin M. Kestenberg-Messina
9 Mar 2026
COO and SVP, Compliance
Sold after exercise
10,096
$15.63
$157.80K
Adam S Grossman
17 Feb 2026
President and CEO
Sold after exercise
6,000
$16.08
$96.48K
Adam S Grossman
17 Feb 2026
President and CEO
Sold after exercise
15,000
$16.08
$241.20K
Adam S Grossman
15 Dec 2025
President and CEO
Sold after exercise
6,000
$19.79
$118.74K
Adam S Grossman
15 Dec 2025
President and CEO
Sold after exercise
15,000
$19.79
$296.85K
Adam S Grossman
19 Nov 2025
President and CEO
Sold after exercise
6,000
$16.00
$96.00K
Adam S Grossman
19 Nov 2025
President and CEO
Sold after exercise
15,000
$16.00
$240.00K
Adam S Grossman
24 Oct 2025
President and CEO
Sold after exercise
6,000
$16.00
$96.00K
Adam S Grossman
24 Oct 2025
President and CEO
Sold after exercise
15,000
$16.00
$240.00K
Adam S Grossman
15 Sep 2025
President and CEO
Sold after exercise
6,000
$16.13
$96.78K
Adam S Grossman
15 Sep 2025
President and CEO
Sold after exercise
15,000
$16.13
$241.95K
Adam S Grossman
15 Aug 2025
President and CEO
Sold after exercise
6,000
$16.88
$101.28K
Adam S Grossman
15 Aug 2025
President and CEO
Sold after exercise
15,000
$16.88
$253.20K
Adam S Grossman
15 Jul 2025
President and CEO
Sold after exercise
6,000
$18.66
$111.96K
Adam S Grossman
15 Jul 2025
President and CEO
Sold after exercise
15,000
$18.66
$279.90K
Adam S Grossman
16 Jun 2025
President and CEO
Sold after exercise
6,000
$20.81
$124.86K
Adam S Grossman
16 Jun 2025
President and CEO
Sold after exercise
15,000
$20.81
$312.15K
Steve Elms
13 Jun 2025
Director
Sold after exercise
137,931
$20.82
$2.87M
Jerrold B Grossman
9 Jun 2025
Director
Sold after exercise
10,000
$21.31
$213.10K
Lawrence P. Guiheen
22 May 2025
Director
Sold after exercise
1,221
$20.12
$24.57K
Lawrence P. Guiheen
21 May 2025
Director
Sold after exercise
7,779
$20.32
$158.07K
Adam S Grossman
15 May 2025
President and CEO
Sold after exercise
6,000
$19.45
$116.70K
Adam S Grossman
15 May 2025
President and CEO
Sold after exercise
15,000
$19.45
$291.75K
Adam S Grossman
15 Apr 2025
President and CEO
Sold after exercise
6,000
$21.46
$128.76K
Adam S Grossman
15 Apr 2025
President and CEO
Sold after exercise
15,000
$21.46
$321.90K
Adam S Grossman
19 Mar 2025
President and CEO
Sold after exercise
6,000
$18.92
$113.52K
Adam S Grossman
19 Mar 2025
President and CEO
Sold after exercise
15,000
$18.92
$283.80K
Lawrence P. Guiheen
9 Sep 2024
Director
Sold after exercise
9,000
$18.47
$166.19K
Kaitlin M. Kestenberg-Messina
30 Aug 2024
COO and SVP, Compliance
Sold after exercise
24,150
$16.90
$408.05K
Jerrold B Grossman
29 Aug 2024
Director
Sold after exercise
136,861
$17.27
$2.36M
Adam S Grossman
27 Aug 2024
President and CEO
Sold after exercise
389,356
$17.29
$6.73M
Adam S Grossman
26 Aug 2024
President and CEO
Sold after exercise
236,889
$17.69
$4.19M
Brian Lenz
15 Aug 2023
EVP, CFO
Sold after exercise
211,578
$4.60
$972.73K
Adam S Grossman
15 Aug 2023
President and CEO
Sold after exercise
510,469
$4.54
$2.32M
Show all 133 transactions →

What was left out

Form 4 filings counted 238
Amendments (4/A) skipped 6
Filings about a different issuer 0
Unreadable filings 0
Joint filings 9
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 38
Sales at will 28
Transactions with no price 0
Shares from compensation/vesting 15,523,958
Sales filed before the plan box existed 12
History held since 13 Feb 2012